Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 16.744\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CCOc1ccc(NC(=O)/C(C#N)=C/c2ccc(N3CCCC3)c(C)c2)cc1
[b] CCOC(=O)CCc1c(C)c2ccc3c(c2oc1=O)CN(CCCO)CO3
[c] CCCC(=O)Nc1ccc(C)c(O)c1
Answer: b. CCOC(=O)CCc1c(C)c2ccc3c(c2oc1=O)CN(CCCO)CO3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)CCc1c(C)c2ccc3c(c2oc1=O)CN(CCCO)CO3
CCOC(=O)CCc1c(C)c2ccc3c(c2oc1=O)CN(CCCO)CO3
ethyl 3-[9-(3-hydroxypropyl)-4-methyl-2-oxo-8,10-dihydropyrano[2,3-f][1,3]benzoxazin-3-yl]propanoate